Monthly Prescribing Reference3d
Labeling for ADHD Med Qelbree Updated With Lactation, Pharmacodynamic Data
The updated labeling for Qelbree provides additional information on the pharmacodynamic profile of the drug. Findings show ...
Supernus announces U.S. FDA approved an update for label for Qelbree
Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to ...
Nasdaq3d
Supernus Pharmaceuticals Announces FDA Approval for Updated Qelbree Label Including New Pharmacodynamic Data and Lactation Information
Supernus Pharmaceuticals, Inc. announced that the FDA has approved an updated label for Qelbree (viloxazine extended-release capsules) to include new pharmacodynamic data, highlighting its ...
Investing3d
FDA approves Qelbree label update for ADHD treatment
The new information in Section 12.2 of the label details Qelbree's partial agonist activity at the serotonin 5-HT2C receptor and its inhibition of the norepinephrine transporter. This multimodal ...
Investing3d
FDA approves Qelbree label update for ADHD treatment
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a label update for ...